Landscape Capital Management, L.L.C. Abb Vie Inc. Transaction History

Landscape Capital Management, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $649,648 - $752,062	4,863 Added 111.18%	9,237 $1.38 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $579,598 - $721,272	4,374 New	4,374 $589,000
Q3 2022 Nov 02, 2022	BUY	$134.21 - $153.93 $957,454 - $1.1 Million	7,134 New	7,134 $957,000
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $5.3 Million - $6.63 Million	-73,437 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $4.63 Million - $5.56 Million	73,437 New	73,437 $5.56 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $1.38 Million - $1.54 Million	-15,556 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $1.4 Million - $1.65 Million	15,556 New	15,556 $1.44 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.